Corporate and Regional Press Releases

Please find below a list of our press releases.

22 May 2017

OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

19 May 2017

BTG and HealthLoop collaborate on IO Loop™, an exclusive service to connect patients and interventional oncologists throughout treatment

Data from a pilot study using IO Loop™ with TheraSphere® (a 90Y transarterial radioembolisation therapy) will be presented at the World Conference on Interventional Oncology

20 Apr 2017

First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads

BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™.

7 Mar 2017

BTG announces CE Mark Certification for DC Bead LUMI™, the first commercially available radiopaque drug-eluting bead in the EU

DC Bead LUMI™ provides real-time visible, lasting confirmation of bead location during and post-embolisation of hypervascular tumours in the liver

15 Feb 2017

BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

BTG plc (LSE: BTG), the global specialist healthcare company, today announced a collaboration with the Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, to explore the role of interventional oncology alongside immuno-oncology

26 Jan 2017

New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians

BTG International Canada Inc., part of global specialist healthcare company BTG (LSE: BTG), today announced the Canadian commercial launch of Varithena™ (polidocanol injectable foam), a drug/device combination product used to treat varicose veins.

26 Jan 2017

Nouveau traitement des varices offrant une intervention non chirurgicale à effraction minimale pour les Canadiens

BTG International Canada Inc., qui fait partie de BTG, une entreprise internationale de soins de santé spécialisés (LSE : BTG), a annoncé aujourd’hui le lancement sur le marché canadien de Varithena™ (mousse injectable à base de polidocanol), une combinaison de médicament et d’appareil utilisé pour traiter les varices.

9 Jan 2017

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® system.

BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available EKOS® system.

5 Dec 2016

PneumRx® Coils included in new global clinical guidelines and given positive recommendation to treat severe emphysema patients in France

BTG plc (LSE: BTG), the global specialist healthcare company, today announces the inclusion of treatment with PneumRx® Coils in guidelines for the management of chronic obstructive pulmonary disease (COPD) published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

5 Dec 2016

Le Canada, premier pays à bénéficier d’une nouvelle option de traitement contre le cancer du foie

Les microsphères radio-opaques à élution médicamenteuse DC Bead LUMIMC offrent aux radiologistes interventionnels du Canada un traitement de nouvelle génération pour les patients atteints d’un cancer du foie

About Us